Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | A |
3. Samples | A |
4. Measurand | B |
5. Pre-Analytical | A |
6. Replicate Analysis | A |
7. Steady State | C |
8. Outlier Analysis | C |
9. Normality | B |
10. Variance Homogeneity | C |
11. ANOVA | C |
12. CI | A |
13. No of Results | C |
14. Concentrations | A |
15. Total Score | C7,8,10,11,13 |
Comment |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Prostate specific antigen (PSA) |
Unit | ng / mL |
Overall Analytical Principle Method | Chemiluminescence |
Number of Subjects | 14 |
Number of Subjects included in BV estimation | 14 |
Ethinicity | Unknown |
Age Mean / Median | 65.0 |
Age Min | |
Age Max | |
Age SD | |
Number of Males | 14 |
Number of Females | 0 |
State of Well Being |
Non-healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 4 |
Study Duration Units | Week |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
Interval Units | Week |
Sampling Times | Start Time:
End Time: |
Number of Samples | 4 |
Average Number of Samples Used for BV Estimation | 4.0 |
Average Number of Replicates | 1.0 |
Estimates of CVi | 14.1 |
Calculated Confidence Intervals of CVi | Lower: 7.72, Upper: 18.39 |
Estimates of CVg | |
Calculated Confidence Intervals of CVg | Lower: , Upper: |
Analytical CV | 5.3 |
Calculated Confidence Intervals of Analytical CV | Lower: 3.31, Upper: 13.00 |
Measurand Mean | 2.5 |
Measurand Min | 0.0 |
Measurand Max | 4.0 |
Measurand SD |